Cello Group (CLL)


CLL Share PerformanceMore

52 week high118.50 09/02/17
52 week low83.75 18/02/16
52 week change 31.25 (37.09%)
4 week volume3,487,130 24/01/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Five AIM shares with hidden gems

Growth companies by their very nature often have parts of the business that could become huge in the future. Former AI...

Result of General Meeting

RNS Number: 1911X Cello Group plc 17 February 2017 Cello Group plc Result of General Meeting Cello Group plc (AIM: CLL; "Cello", the "Group" or the "Company"), the healthcare focused strategic marketing group, is pleased to announce that at its General Meeting held earlier today, all resolutions in connection with the conditional placing of 10,309,279 new ordinar...

Cello acquires Defined Health; raises £15m

Cello Group has raised 15.0m, gross, through a placing of 15,463,919 new ordinary shares at 0.97 and will use part of the proc...

Placing & Acquisition of Defined Health

RNS Number: 6663V Cello Group plc 01 February 2017 For Immediate Release 1 February 2017 Cello Group plc Placing to raise 15.0m and acquisition of Defined Health Cello Group plc (AIM: CLL; "Cello", the "Group" or the "Company), the healthcare focused strategic marketing group, is pleased to announce that it has raised 15.0 million (before expenses) by way of a...

Cello in line with market expectations

Cello Group said it delivered an encouraging trading performance in the year to the end of December with gross profit an...

Pre close trading statement

RNS Number: 5386U Cello Group plc 19 January 2017 For Immediate Release 19 January 2017 Cello Group plc Pre close trading statement Cello Group plc (AIM: CLL; "Cello" or "the Group"), the healthcare focused strategic marketing group, today announces a trading update for the year ended 31 December 2016. The Group has delivered an encouraging trading perfo...

Total Voting Rights

RNS Number: 9032N Cello Group plc 31 October 2016 Cello Group plc Total Voting Rights In conformity with the FCA's Disclosure and Transparency Rules, Cello Group plc ("Cello" or the "Company") confirms the following: As at 31 October 2016 Cello's issued share capital consists of 87,596,492 ordinary shares of 10 pence each ("Ordinary Shares"). The Company hol...

Director/PDMR Shareholding

RNS Number: 7609N Cello Group plc 28 October 2016 28 October 2016 Cello Group plc ("Cello" or the "Company") Director/PDMR Shareholding The Company has received notification that on 27 October 2016, Jane Shirley, a director of Cello Health, exercised share options over 90,000 ordinary shares of 10 pence each in the Company ("Ordinary Shares") at an avera...

Fundamental DataMore

P/E ratio32.627
Dividend yield2.476 %

Latest discussion posts More

  • Re: info

    I was wondering why they raised the extra money. So brokers reckon its for further acquisitions. I hope so, but I was feeling a tad cautious and trimmed my holding a bit ...
    Lupo di mare
  • info

    Finn cap 132p tgt from shares mag Cello has US biotech opportunity in its sights Big demand for shares as marketing firm builds war chest for acquisition Tom ...
  • Today's update

    Hmm, more non-cash impairment charges and non-headine restructuring charge. Like to see an end to those. On the plus side, PULSAR into profit and do we see some retrieval ...
    Lupo di mare

Users' HoldingsMore

Users who hold Cello Group also hold..
RDS 'B'23%

Codes & Symbols